UKIZUK Innovation ZonesA TAIU initiative

Compare places

Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.

Side by side

DimensionSouthampton & PortsmouthSouth EastCambridgeEast of EnglandLeeds & West YorkshireYorkshire and the Humber
Sectors

Defence & Security, Robotics & Autonomous Systems, Advanced Manufacturing

Supporting: Clean Energy, Digital Technologies, Advanced Materials

Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence

Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies

Life Sciences, Digital Technologies, Financial Technology

Supporting: Artificial Intelligence, Advanced Manufacturing, Creative Industries

Research
  • University of Southampton
  • National Oceanography Centre
  • University of Cambridge
  • Wellcome Sanger Institute
  • MRC Laboratory of Molecular Biology
  • University of Leeds
Companies

Not recorded on the map.

  • Cambridge semiconductor and processor IP cluster
  • Leeds health data and digital health cluster
Infrastructure

Not recorded on the map.

Naval and maritime engineering facilities, photonics research centres and port infrastructure.

  • Babraham Research Campus
  • Cambridge Science Park

University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability.

Not recorded on the map.

Health data infrastructure, teaching hospitals and university research facilities.

Capital

Prime contractor supply chain finance and public programmes rather than venture capital.

Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand.

Financial services depth locally, but early-stage health technology capital remains limited.

Government programmes
  • Solent FreeportFreeports

No place-based designation recorded.

No place-based designation recorded.

What existsMaritime, naval and defence engineering, marine autonomy, photonics research and a major port and logistics complex.Extreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines.National health data organisations, medical technology, a large financial and professional services base and a research university with data and materials strength.
What's missing · UKIZ interpretationRoutes for smaller innovators into defence and maritime procurement, and a civil market for capability developed for defence customers.Ownership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth.A clear route for companies to work with health data at scale, and clinical adoption pathways that move faster than pilot projects.
What could connect · UKIZ interpretationMarine autonomy and photonics connected to Plymouth marine capability, Bristol robotics and offshore energy operations — the same technologies serving defence, energy and shipping.Cambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country.Leeds health data capability connected to Manchester clinical research and to medical technology manufacturing, giving companies discovery, evidence and production in one region.
UKIZ relevanceMarine autonomy is where defence, robotics and clean energy meet. The proposed Cornwall & Devon marine mission connects to this capability directly.Cambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford–Cambridge zone concentrates on commercialisation and retention rather than on more discovery.Health data at population scale is a national asset. The proposed Manchester mission and Leeds capability are complementary rather than competing.
Last verified15 August 202615 August 202615 August 2026

Proposed by UKIZ · independent · not a government designation